Pentoxifylline Alone or in Combination with Gentamicin or Vancomycin Inhibits Live Microbe-Induced Proinflammatory Cytokine Production in Human Cord Blood and Cord Blood Monocytes In Vitro
Open Access
- 1 December 2018
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 62 (12)
Abstract
Neonatal sepsis and its accompanying inflammatory response contribute to substantial morbidity and mortality. Pentoxifylline (PTX), a phosphodiesterase inhibitor which suppresses transcription and production of proinflammatory cytokines, is a candidate adjunctive therapy for newborn sepsis. We hypothesized that PTX decreases live microbe-induced inflammatory cytokine production in newborn blood. Cord blood was stimulated with live microorganisms commonly encountered in newborn sepsis (Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis, or Candida albicans) and simultaneously treated with antimicrobial agents (gentamicin, vancomycin, or amphotericin B) and/or clinically relevant concentrations of PTX. Microbial colony counts were enumerated by plating, supernatant cytokines were measured by multiplex assay, intracellular cytokines and signaling molecules were measured by flow cytometry, and mRNA levels were measured by quantitative reverse transcription-PCR. PTX inhibited concentration-dependent E. coli-, S. aureus-, S. epidermidis-, and C. albicans-induced tumor necrosis factor (TNF) and E. coli-induced interleukin-1β (IL-1β) production in whole blood, with greater suppression of proinflammatory cytokines in combination with antimicrobial agents. Likewise, PTX suppressed E. coli-induced monocytic TNF and IL-1β, whereby combined PTX and gentamicin led to significantly greater reduction of TNF and IL-1β. The anti-inflammatory effect of PTX on microbe-induced proinflammatory cytokine production was accompanied by inhibition of TNF mRNA expression and was achieved without suppressing the production of the anti-inflammatory IL-10. Of note, microbial colony counts in newborn blood were not increased by PTX. Our findings demonstrated that PTX inhibited microbe-induced proinflammatory cytokine production, especially when combined with antimicrobial agents, without enhancing microbial proliferation in human cord blood in vitro, thus supporting its utility as candidate adjunctive agent for newborn sepsis.Keywords
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI127704)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R01AI100135-01)
This publication has 49 references indexed in Scilit:
- Plasma‐mediated immune suppression: a neonatal perspectivePediatric Allergy and Immunology, 2012
- Azithromycin distinctively modulates classical activation of human monocytes in vitroBritish Journal of Pharmacology, 2011
- Detection of prokaryotic mRNA signifies microbial viability and promotes immunityNature, 2011
- Method of bacterial killing differentially affects the human innate immune response to Staphylococcus epidermidisInnate Immunity, 2010
- Particle size and activation threshold: a new dimension of danger signalingBlood, 2010
- The Host Response to Sepsis and Developmental ImpactPediatrics, 2010
- Diverse Enterotoxin Gene Profiles among Clonal Complexes of Staphylococcus aureus Isolates from the Bronx, New YorkApplied and Environmental Microbiology, 2009
- Cyclic AMPAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- Gentamicin suppresses endotoxin-driven TNF-α production in human and mouse proximal tubule cellsAmerican Journal of Physiology-Renal Physiology, 2007
- Differential regulation of TNFα, IL-1β, IL-6, IL-8, TNFβ, and IL-10 by pentoxifyllineInternational Journal of Immunopharmacology, 1996